T runcus arteriosus is a rare congenital heart malformation that results from failure of septation of the embryonic truncus arteriosus and failure of normal septation of the conus. A single arterial trunk leaves the heart through a single semilunar valve and supplies the Objective: Truncal valve regurgitation and interrupted aortic arch have frequently been identified as risk factors in the repair of truncus arteriosus. We wished to examine these factors in the current era including the impact of truncal valve repair. Methods: Between January 1992 and August 1998, 50 patients underwent surgical repair of truncus arteriosus. Their ages ranged from 2 days to 6 months (median, 2 weeks). Nine patients had associated interrupted aortic arch. Of the 14 patients (28%) in whom truncal valve regurgitation was diagnosed preoperatively, 5 had mild regurgitation, 5 had moderate regurgitation, and 4 had severe regurgitation. Five underwent truncal valve repair and 1 underwent homograft replacement of the truncal valve with coronary reimplantation. Results: The actuarial survival was 96% at 30 days, 1 year, and 3 years. There were no deaths in patients with associated interrupted aortic arch. The 2 deaths in the series occurred in patients with truncal valve regurgitation, neither of whom underwent repair. 1-60 months) . Conduit replacement has been done in 17 patients (34%) after a mean duration of 2 years. The freedom from reoperation for those who had an aortic homograft was 4 years and for those who had a pulmonary homograft was 3 years. Conclusion: Despite the magnitude of the operation, excellent results can be achieved in complex forms of truncus arteriosus. In the current era interrupted aortic arch is no longer a risk factor for repair of truncus. Aggressive application of truncal valvuloplasty methods should neutralize the traditional risk factor of truncal valve regurgitation. (J Thorac
aorta, one or both pulmonary arteries, and the coronary arteries. The anulus of the truncal valve is larger than a normal semilunar valve and is placed in the normal aortic position. In the majority of cases, the semilunar valve has 2 to 4 cusps, and in rare instances valves with 5 cusps have been reported (tricuspid, 70%; tetracuspid, 23%; bicuspid, 6%; pentacuspid, 2%). 1 In addition to the abnormal number of cusps, there may be commissural imperfection and nodularity causing prolapse. 2 Primary repair of truncus arteriosus during the neonatal period and infancy has become the established practice. 3, 4 The excellent results of surgical repair of truncus arteriosus reported in most centers have not applied to those patients with significant truncal valve regurgitation and associated interrupted arch. Truncal valve dysfunction is estimated to occur in up to 25% of patients with truncus arteriosus. 5 This figure may be an under-estimation of truncal valve dysfunction because of the large runoff of blood to the pulmonary circulation. In some series, valve regurgitation was identified by poor hemodynamic performance when the patient was weaned from cardiopulmonary bypass (CPB). The surgical options for truncal valve regurgitation have been homograft replacement with coronary reimplantation, mechanical valve replacement, and valve repair. The first two options condemn the patient to multiple further operations with risks of eventual valve failure, anticoagulation, and prosthetic valve endocarditis. The recently reported disappointing results of homograft valve replacement 6, 7 make truncal valve repair a more attractive option. In an earlier series from Children's Hospital, Boston, truncal valve regurgitation and interrupted aortic arch were identified as risk factors for perioperative death. 3 The purpose of this study was to examine the treatment of patients with truncal valve regurgitation and interrupted aortic arch in the current era and to compare the outcome in these cases with that in the less complex forms of truncus arteriosus.
Patients and methods
In the previous published series of truncus arteriosus from Children's Hospital, Boston, the cases of patients who had undergone repair between September 1986 and December 1991 were reviewed. 3 The current series encompasses January 1992 to September 1998. The hospital records of all patients who underwent repair of truncus arteriosus between January 1992 and August 1998 were reviewed. There were no patients with the diagnosis of truncus arteriosus who died before operation. Fifty patients were identified: 31 boys and 19 girls. The ages ranged from 2 days to 6 months (median, 2 weeks). Weights ranged from 1.6 kg to 6.1 kg (median, 3.1 kg). Three patients were born prematurely, 2 at 31 weeks' gestation and 1 at 30 weeks' gestation, weighing at birth 1.6, 1.6, and 1.4 kg, respectively. All patients underwent primary repair. Diagnosis was made in all patients by transthoracic echocardiography alone. Repair was achieved in 37 patients (74%) in the first month of life. The delayed repair in the remainder was because of late referral. Associated cardiac anomalies are shown in Table I .
Surgical technique. The repair was done with the use of deep hypothermia with continuous CPB or reduced flow usually with a single venous cannula. A period of circulatory arrest was used in 15 patients (30%). The CPB, crossclamp, and circulatory arrest times are shown in Table II . The truncus was usually divided at the level of takeoff of the pulmonary arteries and great care was taken to ensure that an adequate margin from the coronary arteries was maintained. The truncal root was anastomosed to the ascending aorta. This necessitated considerable tailoring of the large truncal root, which may have improved valve leaflet apposition. The ventricular septal defect was approached through the right ventriculotomy and was closed with interrupted pledget-supported sutures using glutaraldehyde-treated autologous pericardium or Dacron fabric. The right ventricular outflow tract was reconstructed with either an aortic or pulmonary homograft. The patent foramen ovale was left open, and if this was not patent a small atrial communication was made.
Patients with truncal valve regurgitation. Fourteen patients (28%) with truncal valve regurgitation were identified preoperatively. Of the 14 patients, 5 had mild regurgitation, 5 had moderate regurgitation, and 4 had severe regurgitation. Five patients with moderate to severe regurgitation underwent valve repair and 1 patient underwent homograft root replacement. Three patients with moderate truncal valve regurgitation did not undergo repair. These patients were from the earlier part of the series when truncal valve problems were not specifically addressed.
The principle of valve repair was improved leaflet apposition. This was achieved by approximation of the incomplete commissures and resuspension of the true commissures. The rudimentary commissures were closed with 7-0 Prolene polypropylene sutures supported with pericardial pledgets. If there was some redundancy in the anulus, this was reduced by taking a tuck at the attachment of the raphe of the commissure and the aortic wall. Reduction of the sinuses of Valsalva was done when indicated. Three patients had quadricusp valves, in which 2 cusps were relatively normal and the other 2 cusps were partially fused at a rudimentary commissure. One patient had 5 leaflets with 3 large leaflets and 2 additional leaflets. The fifth patient had a bicuspid valve. A 5-dayold neonate weighing 2.9 kg with severe truncal valve regurgitation underwent homograft root replacement (aortic homograft, 11 mm) with coronary reimplantation. This patient was operated on early in the series.
Patients with interrupted aortic arch. Associated interrupted aortic arch was repaired in 9 patients. Eight patients had type B and 1 patient had type A interrupted arch. The median age was 17 days (range, 4 days-6 months). Seven patients were younger than 1 month old, 1 was 6 weeks old, and another was 6 months old. None of the patients with associated interrupted aortic arch had truncal valve regurgitation.
After wide mobilization of the ascending and descending aorta and control of the arch vessels, direct anastomosis was 8 using the following variables: age, weight at operation, sex, presence of truncal valve regurgitation, interrupted aortic arch, CPB time, and crossclamp time. Percent survival at 30 days, 1 year, and 3 years and freedom from reoperation were determined by the Kaplan-Meier product-limit method and a 95% confidence interval estimated by the Greenwood formula. 9 Two-tailed values of probability (P) were determined. Data analysis was done with the SPSS software package (version 8.0, SPSS Inc, Chicago, Ill).
Results
There were 2 perioperative deaths (4%) in 50 patients who underwent repair of truncus arteriosus and associated lesions. One death occurred in the first year of this series. This was in a 5-day-old boy weighing 2.9 kg who had severe truncal valve regurgitation. He underwent homograft root replacement with reimplantation of the coronary arteries. CPB was ceased with administration of large doses of inotropic agents. The chest was left open. In the early postoperative period, respiratory failure and abdominal distension developed. An attempt at insertion of a peritoneal dialysis catheter resulted in liver hemorrhage. The patient died on postoperative day 4.
The second death was in a 2-week-old boy weighing 3.5 kg. This patient had mild to moderate truncal valve regurgitation and dual origin of the left anterior descending coronary artery. After repair, the patient was weaned from CPB with moderate support. He had complete heart block and pacing was required. One hour after arrival in the intensive care unit he had a cardiac arrest and after resuscitation was placed on extracorporeal membrane oxygenation (ECMO) support.
There was no suggestion of tamponade or pulmonary hypertensive crisis accounting for the arrest. The next 48 hours were complicated by severe coagulopathy and bleeding. Transesophageal echocardiography revealed poor left ventricular function and a thrombosed conduit. The patient was returned to the operating room for replacement of the conduit and subsequently was maintained on ECMO support for a further 48 hours. His course was complicated by Aspergillus mediastinitis. It was also demonstrated that the excised homograft was infected with Aspergillus. All attempts at weaning from ECMO were unsuccessful and at this point the patient had overwhelming sepsis. Resuscitation was ceased.
Patients with truncal valve regurgitation. There were 2 deaths in the group of patients with truncal valve regurgitation. Both cases were discussed in the preceding section. Of the 5 patients who underwent truncal valve repair, none died. Two patients had transesophageal echocardiography done in the operating room after weaning from CPB that showed minimal valvular regurgitation. Transthoracic echocardiography done after the operation in all patients having repair showed mild valvular regurgitation in 2 patients and 3 patients had no truncal valve regurgitation.
Transthoracic echocardiography at the most recent follow-up showed minimal valvular regurgitation in the 5 patients who underwent repair. Of the 8 patients who did not undergo truncal valve repair or replacement, 5 with mild truncal valve regurgitation and 2 with moderate truncal valve regurgitation did not have any deterioration of valve function at follow-up. One patient with moderate valvular regurgitation has had some deterioration in valve function.
Patients with associated interrupted aortic arch. There were no deaths in the group of patients with associated interrupted aortic arch, and the median hospital stay was not significantly different from the stay in those patients without interrupted aortic arch. Obstruction across the arch anastomosis was defined as a pressure gradient of 30 mm Hg or greater defined by transthoracic echocardiography. At follow-up, none of the patients had any degree of arch obstruction. Freedom from reoperation. Conduit replacement has been done in 17 patients (34%) with a median interval of 3 years. The median aortic homograft size at the initial operation was 10 mm and the median pulmonary homograft size was also 10 mm. The median time for reoperation for patients who had an aortic homograft was 4 years (range, 8 months-7 years) and for those who had a pulmonary homograft, 3 years (range, 11 months-4 years). This difference was not significant (P = .87). By the Cox proportional hazard model, patients with a larger homograft size had a longer period of freedom from conduit replacement. None of the patients has required reoperation because of truncal valve problems or aortic arch stenosis. The actuarial survival was 96% at 30 days, 1 year, and 3 years (Fig 1) . Freedom from reoperation is shown in Fig 2. Follow-up. The follow-up was complete in all 48 patients (median, 23 months; range, 1-60 months). The mean follow-up for patients with interrupted aortic arch was 13 months (range, 1-48 months) and for patients with truncal valve regurgitation, 14 months (range, 3-36 months).
Discussion
In this study, the more complex forms of truncus arteriosus, those with truncal valve regurgitation and associated interrupted aortic arch, are analyzed. These associated anomalies were previously identified as risk factors for death after repair of truncus arteriosus. 3 The disappointing results of truncal valve replacement and the success of aortic valve repair in the adult population have increased interest in the repair of truncal valve insufficiency. [10] [11] [12] In this study, 5 patients underwent truncal valve repair. In all 5 patients, truncal valve insufficiency was diagnosed preoperatively and therefore valve repair was a planned procedure. In the most recent previous series from Children's Hospital, Boston, 4 of 8 patients with truncal valve insufficiency died. On further analysis of the 4 deaths, only 1 patient had replacement as a planned part of the primary repair. In another, valve replacement was done after failure to wean from CPB. Two patients died in the perioperative period before valve replacement could be accomplished. Of the 4 patients who survived, 2 underwent perioperative valve replacement and 2 underwent replacement at 6 and 12 months, respectively. In the current series, none of the patients who underwent truncal valve repair has required intervention at a median follow-up of 14 months (range, 3-36 months).
It is thought that nodular or dysmorphic valves are more likely to be insufficient and have an abnormal number of leaflets 2 and that quadricusp valves are more regurgitant than tricuspid valves. 13 In this study, the number of patients who underwent truncal valve repair is too small to extrapolate as to which type of valve would best be served by valvuloplasty techniques. Most probably, conversion of a quadricusp valve to a tricuspid valve will be most productive, because it will restore a trileaflet morphology. It may be that repair resulting in bicuspid morphology would predispose to future valve stenosis.
The results of truncal valve replacement have been disappointing. In the current series, the 1 patient who underwent truncal valve replacement because of valve regurgitation died in the postoperative period. Elkins and colleagues 7 have reported the cases of 4 patients who underwent homograft replacement of the truncal valve, 2 of whom died in the early postoperative peri-od. In a report by McElhinney and colleagues, 14 3 of the 4 neonates who received allograft root replacement died within 7 months after repair and the fourth required replacement after 1 year because of severe homograft insufficiency. Four of their 6 patients who required mechanical valve replacement died in the early postoperative period. The risks of mechanical valve replacement in the small truncal root, impairing normal growth of the native anulus as well as subjecting the child to long-term anticoagulation, should be weighed against potential benefits.
The results in this series with associated interrupted arch have improved significantly compared with results in the previous report, 3 in which 3 of 6 patients died after repair. There were no deaths in the 9 patients who underwent complete repair. Of the 9 patients who underwent repair, 7 were younger than 1 month old.
We advocate direct anastomosis between the ascending and the descending aorta. A gusset of homograft can be used for augmentation of the anastomosis if there is important size disparity. Others have suggested the use of subclavian artery in type A interrupted aortic arch and the use of both the subclavian and the left carotid arteries in type B interrupted aortic arch. 15 In this method, the arch vessels are divided distally and then filleted open to form the superior part of the neo-aortic arch. Those authors believe that the risk of stenosis is reduced. However, this has to be balanced against the risk of cerebral damage. 16 At a mean follow-up of 13 months (range, 1-48 months), none of the patients in our series has been seen because of restenosis. Although the follow-up is too short in this group to draw any inferences regarding the method of repair, it is unlikely that circumferential anastomosis per se will result in stenosis, as has been shown in infants and neonates who have undergone the arterial switch operation. 17 In conclusion, despite the magnitude of this operation, excellent results can be achieved in complex forms of truncus arteriosus. We advocate complete onestage repair in these patients. In patients with truncal valve regurgitation, valve repair is a preferable option to valve replacement. In the current era, associated interrupted aortic arch may no longer be associated with increased mortality in patients undergoing repair of truncus arteriosus. a number of factors, including earlier age at operation, better preoperative and postoperative management, and increased experience with the repair of arch abnormalities of all kinds in neonates, have played significant roles. Importantly, however, the results presented today also indicate that truncal valve repair is a particularly useful option in the management of significant truncal valve regurgitation. This knowledge will allow surgeons to avoid the delay in operation that has so often been used when the truncal valve must be dealt with and also to avoid the technical complexity introduced by truncal valve replacement itself, thus removing arguably the two most significant risk factors associated with the need for truncal valve replacement.
A few years ago, our group reported excellent survival with severe truncal valve regurgitation when truncal valve replacement was undertaken without delay, even in neonates, indicating that delaying the operation plays an important role in the outcome, as also demonstrated for uncomplicated truncus, and that operating on a patient with worsening left ventricular dysfunction and in poor preoperative condition was itself associated with a higher risk. Thus prompt truncal valve replacement can be done satisfactorily. However, the problems associated with the need for repeated replacement of the truncal valve in growing babies present yet another set of risks that can and should be avoided by early valve repair as demonstrated by the authors. However, although it appears that repair is possible even in severely malformed valves, the limitations of this technique are not fully understood.
Similarly outstanding results can now be expected with associated interruption of the arch, a condition that has not posed an increased risk in our institution for a considerable time. The authors prefer a primary anastomosis, a technique with which we would agree, although arch augmentation with a homograft patch is another useful tool that allows for a better size match between the distal aorta and the often small segment of ascending aorta that is left after removal of the duct and the pulmonary arteries. We have increasingly used the Lecompte maneuver to translocate the branch pulmonary arteries anteriorly to facilitate conduit placement.
I have three main questions for Dr Jonas. First, you used repair of the truncal valve in 5 of the 9 patients in your series who had at least moderate regurgitation. Although no doubt your indications were evolving over time, could you tell us why the other 4 patients were not treated in a similar fashion and what their postoperative outcomes and echocardiograms showed? Do you now recommend repair for any patient with at least moderate regurgitation?
Second, have you identified any morphologic characteristics of the truncal valve that may be predictive of successful repair? In particular, what about those valves that are very immobile, often with significant degrees of stenosis? It has certainly been our experience that patients with severe truncal valve regurgitation also have gradients across the valve, admittedly because of the large volume flow, but often also because of the very thickened and immobile leaflets.
Finally, have you seen any bronchial obstruction after your technique of repair of the interrupted aortic arch?
